OpenEvidence vs DxGPT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

OpenEvidence

by OpenEvidence

DxGPT

by AI Agent

AI Verdict

Both OpenEvidence and DxGPT offer AI-powered clinical decision support, making them adjacent competitors. OpenEvidence focuses on providing referenced answers from medical literature and integrating documentation workflows, while DxGPT specializes in generating differential diagnoses for complex and rare diseases with a strong emphasis on data privacy and multilingual support.

Choose OpenEvidence if…

Choose OpenEvidence if you need immediate, evidence-based answers to clinical questions, supported by peer-reviewed medical literature, to inform high-stakes decisions at the point of care. It is also ideal for streamlining clinical documentation by transcribing patient visits and auto-generating structured medical notes, integrating real-time clinical decision support into your workflow.

View OpenEvidence →

Choose DxGPT if…

Choose DxGPT if you are a physician or patient seeking rapid, structured differential diagnoses, especially for complex and rare diseases. It excels at providing prioritized lists of possible diagnoses, along with detailed disease information and follow-up questions, while ensuring data privacy and offering multilingual support.

View DxGPT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	OpenEvidence	DxGPT
Pricing	Free	Free
Deployment	Cloud-based (web application) and mobile applications	Cloud, On-premise (self-hosted version for healthcare providers)

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools prioritize ease of use. OpenEvidence offers a web and mobile application with a ChatGPT-like interface, designed for quick clinical queries and documentation. DxGPT is also a web application that allows users to input symptoms in natural language and has received favorable reviews for its usability and simplicity from clinicians.

Clinical Value

OpenEvidence

OpenEvidence excels in providing immediate, referenced answers from peer-reviewed medical literature, directly supporting high-stakes clinical decisions and documentation workflows. While DxGPT offers intelligent differential diagnoses, its clinical validation is still primarily in preprint and focuses on rare diseases, and some studies suggest it may not consistently recommend seeking further medical attention.

Pricing & Value

DxGPT

DxGPT is entirely free to use for both physicians and patients, developed as a non-profit project funded by donations and grants, emphasizing equitable access. OpenEvidence is free for verified U.S. healthcare professionals but operates on an ad-supported model, with enterprise pricing for EHR integration and data insights, which may introduce hidden costs or biases.

Enterprise Readiness

OpenEvidence

OpenEvidence demonstrates strong enterprise readiness with existing integrations into EHR systems like Epic at major health systems such as Mount Sinai, Sutter Health, and Cedars-Sinai. It also offers enterprise pricing models for EHR integration and data insights. DxGPT offers API integration into EHRs, apps, or patient portals but its primary deployment as a non-profit project may limit its enterprise-level support and scalability compared to OpenEvidence's established partnerships and funding.

Innovation

Tie

Both tools showcase innovation in different aspects. OpenEvidence's innovation lies in its comprehensive integration of AI-powered natural language querying with real-time clinical documentation and its partnerships with major medical journals. DxGPT innovates by focusing on structured differential diagnoses for complex and rare diseases, multilingual support, and a GDPR-ready architecture with automatic anonymization.

Support & Docs

Tie

Both tools are relatively new in the market, and detailed public information on their dedicated support channels and comprehensive documentation is not extensively available. OpenEvidence's widespread adoption and enterprise integrations suggest a level of inherent support, while DxGPT, as a non-profit, emphasizes collaboration with healthcare professionals for ongoing development and validation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	OpenEvidence	DxGPT
Name	OpenEvidence	DxGPT
Tagline	America's Official Medical Knowledge Platform	AI-Powered Diagnostic Decision Support: Your Co-Pilot for Complex & Rare Diseases
Key Feature 1	AI-powered natural language question answering for clinical queries	Intelligent differential diagnosis with prioritized lists
Key Feature 2	Answers grounded in peer-reviewed medical evidence (NEJM, JAMA, NCCN, Cochrane, PubMed)	Multilingual support with automatic language detection and translation
EHR Integration	Integrates with Electronic Health Record (EHR) systems like Epic	Integration into EHR, apps, or patient portals via API
Specialties	Family Medicine, Hospital Medicine, Internal Medicine	Emergency Medicine, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring OpenEvidence and DxGPT.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do OpenEvidence and DxGPT differ in their core clinical utility for a physician?

OpenEvidence focuses on providing immediate, referenced answers to broad clinical questions from peer-reviewed literature and offers tools for clinical documentation. DxGPT specializes in generating rapid, structured differential diagnoses, particularly for complex and rare diseases, and provides detailed disease information and follow-up questions.

What is the depth of EHR integration for each tool, and how does it impact workflow?

OpenEvidence integrates with EHR systems like Epic, providing real-time clinical decision support directly within documentation workflows and transcribing patient visits into structured notes. DxGPT offers API integration into EHRs, apps, or patient portals, enabling its diagnostic support to be embedded into existing systems, though specific workflow impacts beyond diagnosis are less detailed.

Given their different focuses, how might the 'accuracy' or 'sensitivity' of each tool be best evaluated by a physician?

For OpenEvidence, accuracy can be evaluated by the transparency and direct sourcing of its answers to primary studies and guidelines from official partners like NEJM and JAMA. For DxGPT, sensitivity would be assessed by its ability to generate comprehensive and prioritized differential diagnoses for complex and rare conditions, identifying subtle patterns that might be missed.

Beyond standard compliance, what specific security or data privacy features do these tools offer?

OpenEvidence emphasizes its role as an 'Official Medical Knowledge Platform' with transparent sourcing, implying a focus on data integrity for clinical information. DxGPT highlights a 'GDPR-ready architecture' with automatic anonymization of sensitive data, indicating a proactive approach to patient data privacy beyond basic compliance.

What is the learning curve for physicians to effectively use each tool in their daily practice?

OpenEvidence, with its natural language question answering and direct integration into documentation, likely has a relatively low learning curve for accessing information and generating notes. DxGPT, while providing structured differential diagnoses, might require a brief period for physicians to familiarize themselves with its specific output format and how to best interpret its diagnostic hypotheses and follow-up questions.

Are there any specific clinical contexts or specialties where one tool would be significantly more beneficial than the other?

OpenEvidence appears highly beneficial for specialties requiring constant access to broad, evidence-based clinical information and efficient documentation, such as Family Medicine, Hospital Medicine, and Internal Medicine. DxGPT's focus on complex and rare diseases makes it particularly valuable for specialties like Emergency Medicine, where rapid, comprehensive differential diagnoses are critical, in addition to Family and Internal Medicine.

Can physicians access customer references or case studies to understand real-world implementation and benefits?

OpenEvidence's partnerships with major medical journals and its 'Official AI Partner' status suggest a strong foundation and potential for readily available references or endorsements. DxGPT, as a non-profit project by Foundation29, might offer case studies or testimonials focused on its diagnostic accuracy and utility in complex cases, though specific customer reference availability is not detailed.